Organic Letters
Letter
(16) For examples of the stereolability of 2° α-amido cuprates, see:
Dieter, R. K.; Topping, C. M.; Chandupatla, K. R.; Lu, K. J. Am. Chem.
Soc. 2001, 123, 5132.
grateful to MSD for support of this program. We thank Andy
Gibb, Alexandra Ridge, and David Murray (Hoddesdon
Analytical Chemistry) for chiral SFC, HRMS, and LCMS
support, respectively, and Ed Cleator and Jeremy Scott
(Hoddesdon Process Chemistry) for critical reading of this
manuscript.
REFERENCES
■
(1) For recent publications on the synthesis of aminoboronates, see:
(a) Nishikawa, D.; Hirano, K.; Miura, M. J. Am. Chem. Soc. 2015, 137,
15620. (b) Wang, D.; Cao, P.; Wang, B.; Jia, T.; Lou, Y.; Wang, M.; Liao,
J. Org. Lett. 2015, 17, 2420. (c) Buesking, A. W.; Bacauanu, V.; Cai, I.;
Ellman, J. A. J. Org. Chem. 2014, 79, 3671. (d) Hong, K.; Morken, J. P. J.
Am. Chem. Soc. 2013, 135, 9252. (e) Matteson, D. S. J. Org. Chem. 2013,
́ ́ ́
78, 10009. (f) Sole, C.; Gulyas, H.; Fernandez, E. Chem. Commun. 2012,
48, 3769. (g) He, Z.; Zajdlik, A.; St. Denis, J. D.; Assem, N.; Yudin, A. K.
J. Am. Chem. Soc. 2012, 134, 9926. For a comprehensive recent review,
see: (h) Andres, P.; Ballano, G.; Calaza, M. I.; Cativiela, C. Chem. Soc.
́
(2) Greener, B. S.; Millan, D. S. Bortezomib (Velcade): A First-in-Class
Proteasome Inhibitor. In Modern Drug Synthesis; Li, J. J., Johnson, D. S.,
Eds.; John Wiley & Sons, Inc.: Hoboken, NJ, 2010; pp 99−110.
(3) Pd-catalyzed: (a) Molander, G. A.; Shin, I. Org. Lett. 2013, 15,
2534. (b) Molander, G. A.; Shin, I. Org. Lett. 2012, 14, 4458.
(c) Molander, G. A.; Shin, I. Org. Lett. 2012, 14, 3138. (d) Molander, G.
A.; Shin, I. Org. Lett. 2011, 13, 3956. (e) Molander, G. A.; Sandrock, D.
L. Org. Lett. 2007, 9, 1597. Ni/Ir-catalyzed: (f) El Khatib, M.; Serafim,
R. A. M.; Molander, G. A. Angew. Chem., Int. Ed. 2016, 55, 254.
(4) (a) Awano, T.; Ohmura, T.; Suginome, M. J. Am. Chem. Soc. 2011,
133, 20738. (b) Ohmura, T.; Awano, T.; Suginome, M. J. Am. Chem. Soc.
2010, 132, 13191. (c) Ohmura, T.; Awano, T.; Suginome, M. Chem. Lett.
2009, 38, 664.
(5) Buesking, A. W.; Ellman, J. A. Chem. Sci. 2014, 5, 1983.
(6) Llaveria, J.; Leonori, D.; Aggarwal, V. K. J. Am. Chem. Soc. 2015,
137, 10958.
(7) For selected recent examples of alternative methods of preparing
isoindolinones, see: (a) Tjutrins, J.; Shao, J. L.; Yempally, V.; Bengali, A.
A.; Arndtsen, B. A. Organometallics 2015, 34, 1802. (b) Wang, H.-L.;
Shang, M.; Sun, S.-Z.; Zhou, Z.-L.; Laforteza, B. N.; Dai, H.-X.; Yu, J.-Q.
Org. Lett. 2015, 17, 1228. (c) Zhang, Y.; Wang, D.; Cui, S. Org. Lett.
2015, 17, 2494. (d) Liang, H.-W.; Ding, W.; Jiang, K.; Shuai, L.; Yuan, Y.;
Wei, Y.; Chen, Y.-C. Org. Lett. 2015, 17, 2764. (e) Dhanasekaran, S.;
Kayet, A.; Suneja, A.; Bisai, V.; Singh, V. K. Org. Lett. 2015, 17, 2780.
(f) Wertjes, W. C.; Wolfe, L. C.; Waller, P. J.; Kalyani, D. Org. Lett. 2013,
15, 5986.
(8) Murphy, J. M.; Liao, X.; Hartwig, J. F. J. Am. Chem. Soc. 2007, 129,
15434.
(9) Aminoboronate salts were conveniently prepared by HCl
deprotection of the corresponding t-butanesulfinamides; see Supporting
(10) We were unable to test more electron-withdrawing substituents
such as p-CF3 due to the instability of the precursors to the
deprotection/protonation step that generates the amine salts.
(11) Metal-promoted activation of quaternary aminoboronates for C−
C bond formation is relatively unexplored. For a single example of Rh-
catalyzed addition to aldehydes, see: Hu, N.; Zhao, G.; Zhang, Y.; Liu,
X.; Li, G.; Tang, W. J. Am. Chem. Soc. 2015, 137, 6746.
(12) Thapa, S.; Shrestha, B.; Gurung, S. K.; Giri, R. Org. Biomol. Chem.
2015, 13, 4816.
(13) Benzylic boronates are known to form benzyl radicals in the
presence of Cu(II), see: (a) Liwosz, T. W.; Chemler, S. R. Org. Lett.
2013, 15, 3034. (b) Sorin, G.; Mallorquin, R. M.; Contie, Y.; Baralle, A.;
Malacria, M.; Goddard, J.-P.; Fensterbank, L. Angew. Chem., Int. Ed.
2010, 49, 8721.
(14) Tiecco, M. Acc. Chem. Res. 1980, 13, 51−57.
(15) Gurunk, S. K.; Thapa, S.; Kafle, A.; Dickie, D. A.; Giri, R. Org. Lett.
2014, 16, 1264.
D
Org. Lett. XXXX, XXX, XXX−XXX